Oxidative damage can be spurred on by disease, recreational drug use, alcohol use, medications, and many other processes
While it is possible to combine all three, it is rarely necessary and may increase the risk of side effects without proportional benefits
Nasal delivery is not pharmacokinetically equivalent to subcutaneous injection, but for short-chain peptides like ipamorelin, absorption through nasal mucosa can support meaningful bioavailability with reasonable dose adjustment
Researchers aiming for sub-100mcg precision should target concentrations between 2.55mg/mL, which requires larger reconstitution volumes: a 10mg vial needs 24mL bacteriostatic water, while a 15mg vial needs 36mL to hit that range
INCRELEX (mecasermin) injection Highlights of Prescribing Information (2025 revision)
Some patients report relief after a few weeks, but complete optimization may take a few months